![Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response | Cell Death & Disease Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-019-1871-z/MediaObjects/41419_2019_1871_Fig1_HTML.png)
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response | Cell Death & Disease
NSS-SY Spotlight: Genba walk – Pumpwell workers support the fleet every day, working behind the scenes, between dockings and undockings, to keep PSNS & IMF dry docks operational > Naval Sea Systems
![JPM | Free Full-Text | Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe JPM | Free Full-Text | Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe](https://pub.mdpi-res.com/jpm/jpm-12-00072/article_deploy/html/images/jpm-12-00072-g001.png?1642565540)
JPM | Free Full-Text | Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe
![JPM | Free Full-Text | Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams JPM | Free Full-Text | Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams](https://www.mdpi.com/jpm/jpm-11-01296/article_deploy/html/images/jpm-11-01296-g001.png)
JPM | Free Full-Text | Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams
2019 NSWC STEM Science Fair & Expo creates unique learning environment for regional students > Naval Sea Systems Command > News
![Dai-Ichi Life Holdings, Inc. ADR 2018 Q4 - Results - Earnings Call Slides (OTCMKTS:DLICY) | Seeking Alpha Dai-Ichi Life Holdings, Inc. ADR 2018 Q4 - Results - Earnings Call Slides (OTCMKTS:DLICY) | Seeking Alpha](https://static1.seekingalpha.com/uploads/sa_presentations/219/28219/slides/2.jpg?1527098187)